Trial intelligence / Profile preview

PENG Block for Postoperative Rehabilitation in Total Hip Arthroplasty

NCT05944380Phase 4Completed

Sponsor
Poznan University of Medical Sciences
Start
Jun 2020
Primary completion
Jun 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing PENG with Ropivacaine with PENG with Placebo (2 arms). Primary endpoint: Postoperative Numeric Pain Rating Scale in motion at Day 4. Started Jun 2020; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05944380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05944380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call